- New study published in the Journal of Pain Research on PainChek® confirms its accuracy.
- PainChek® demonstrated excellent performance with high sensitivity (96.1%), high specificity (91.4%) and high clinical accuracy (95.0%).
- High scores for clinical usefulness of the new technology (95.0%) demonstrates its value in the clinical setting to clinicians and carers.
A third peer reviewed study has been published in the Journal of Pain Research which supports the clinical usefulness of PainChek®. In order to attract widespread clinical use, it is important to confirm both the accuracy and usefulness of the technology compared to existing methods for assessing pain. Clinicians will naturally ask themselves “Does the new tool work and is it as good as what we already use?”
PainChek Ltd CEO Philip Daffas said “These results, combined with previous studies, support the clinical usefulness of PainChek® and further confirms its accuracy in detecting and quantifying pain in non-verbal people, such as those with advanced dementia. The findings also provide clinicians with great confidence for wider uptake of the tool in clinical practice in Australia and internationally”.
The new study confirmed the accuracy (measurements of correct classification) and usefulness (measures of clinical decision making) of the tool based on 400 paired pain assessments for 34 aged care residents (age range: 68.0-93.2 years old). The residents in the study had moderate to severe dementia.
Using the Abbey Pain Scale as a comparator, PainChek® demonstrated excellent performance with high sensitivity, specificity, and accuracy. The study also showed the excellent clinical utility (i.e. clinical usefulness) of PainChek® in screening and finding cases of pain among those residents.
The study can be accessed here: http://www.dovepress.com/clinimetric-properties-of-the-electronic-pain-assessment-tool-epat-for-peer-reviewed-article-JPR
